Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Devroe Eric received 72,981 Acrivon Therapeutics, Inc. shares as an award (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Devroe Eric (Chief Operating Officer) received 72,981 Acrivon Therapeutics, Inc. shares as an award, leaving 146,953 shares. Filed May 20, 2026 (Form 4).
- Awarded
- 72,981 shares
- Holding after
- 146,953 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Award | 72,981 | 146,953 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Devroe Eric
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Devroe Eric · Nov 19, 2026
- Form 4 · Devroe Eric · Aug 20, 2026
- Form 4 · Devroe Eric · May 18, 2026
- Form 4 · Blume-Jensen Peter · Nov 19, 2026
- Form 4 · Peterson Katharine · Nov 19, 2026
- Form 4 · Miller Mary · Nov 19, 2026
- Form 4 · Gamelin Erick · Nov 19, 2026
- Form 4 · Miller Mary · Oct 26, 2026